Changes in symptoms and plasma homovanillic acid with amantadine hydrochloride in chronic schizophrenia

Biol Psychiatry. 1997 May 15;41(10):1062-4. doi: 10.1016/S0006-3223(97)00003-6.

Authors

K Yamada¹, S Kanba, K Ohnishi, I Ashikari, G Yagi, M Asai

Affiliation

¹ Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan.

PMID: 9129786
DOI: 10.1016/S0006-3223(97)00003-6

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Amantadine / adverse effects
Amantadine / therapeutic use*
Chronic Disease
Dopamine Agents / adverse effects
Dopamine Agents / therapeutic use*
Dose-Response Relationship, Drug
Drug Administration Schedule
Dyskinesia, Drug-Induced / blood
Dyskinesia, Drug-Induced / drug therapy
Dyskinesia, Drug-Induced / psychology
Homovanillic Acid / blood*
Humans
Male
Middle Aged
Neurologic Examination / drug effects
Psychiatric Status Rating Scales
Schizophrenia / blood
Schizophrenia / drug therapy*
Schizophrenic Psychology*

Substances

Dopamine Agents
Amantadine
Homovanillic Acid